Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

Cited by (870)

Items 101–200 of 870

1. Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial
   Jason V. Baker, Shweta Sharma, Birgit Grund, Adam W. Rupert, Julia A. Metcalf, Mauro Schechter, Paula Munderi, Inka Aho, Sean Emery, Abdel G. Babiker et al. · 2017 · Open Forum Infectious Diseases
2. Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV
   Laura W. Musselwhite, Virginia Sheikh, Thomas D. Norton, Adam W. Rupert, Brian O. Porter, Scott R Penzak, Jeff Skinner, JoAnn M. Mican, Colleen M. Hadigan, Irini Sereti · 2011 · AIDS
3. Biomarkers of Immune Dysfunction Following Combination Antiretroviral Therapy for HIV Infection
   Gregor F. Lichtfuss, Jennifer Hoy, Reena Rajasuriar, Marit Kramski, Suzanne M. Crowe, Sharon R. Lewin · 2011 · Biomarkers in Medicine
4. Immune activation and HIV persistence
   Hiroyu Hatano · 2013 · Current Opinion in HIV and AIDS
5. Impact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damage
   Reena Rajasuriar, Edwina Wright, Sharon R. Lewin · 2014 · Current Opinion in HIV and AIDS
6. Insulin Resistance in HIV-Patients: Causes and Consequences
   Marcelo N. Pedro, Guilherme Z. Rocha, Dioze Guadagnini, Andrey Santos, Daniéla Oliveira Magro, Heloísa Balan Assalin, Alexandre Gabarra Oliveira, Rogério de Jesus Pedro, Mário J.A. Saad · 2018 · Frontiers in Endocrinology
7. Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals
   Eric Alexander Secemsky, Rebecca Scherzer, Elaine M. Nitta, Alan H.B. Wu, David C. Lange, Steven G. Deeks, Jeffrey N. Martin, James Snider, Peter Ganz, Priscilla Y. Hsue · 2015 · JACC Heart Failure
8. Dimethyl Fumarate Modulation of Immune and Antioxidant Responses: Application to HIV Therapy
   Alexander J. Gill, Dennis L. Kolson · 2013 · Critical Reviews in Immunology
9. HIV Infection and Risk of Cardiovascular Diseases Beyond Coronary Artery Disease
   Revery P. Barnes, John Charles A. Lacson, Hossein Bahrami · 2017 · Current Atherosclerosis Reports
10. Association between Use of HMG CoA Reductase Inhibitors and Mortality in HIV-Infected Patients
    Richard D. Moore, John Gilles Bartlett, Joel E. Gallant · 2011 · PLoS ONE
11. Accelerated aging and human immunodeficiency virus infection: Emerging challenges of growing older in the era of successful antiretroviral therapy
    Ramona Bhatia, Patrick Ryscavage, Babafemi Taiwo · 2011 · Journal of NeuroVirology
12. HIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Era
    Ceri Evans, Jean H. Humphrey, Robert Ntozini, Andrew J. Prendergast · 2016 · Frontiers in Immunology
13. Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART
    Birgitte Stiksrud, Piotr Nowak, Felix Chinweije Nwosu, Dag Kvale, Anders Thalme, Anders B. Sönnerborg, Per Magne Ueland, Kristian Holm, Stein‐Erik Birkeland, Anders Erik Astrup Dahm et al. · 2015 · JAIDS Journal of Acquired Immune Deficiency Syndromes
14. Contribution of HIV infection to mortality among cancer patients in Uganda
    Anna E. Coghill, Polly A. Newcomb, Margaret M. Madeleine, Barbra A. Richardson, Innocent Mutyaba, Fred Machyo Okuku, Warren T. Phipps, Henry Wabinga, Jackson Orem, Corey Casper · 2013 · AIDS
15. The Many Faces of Immune Activation in HIV-1 Infection: A Multifactorial Interconnection
    Laura Mazzuti, Ombretta Turriziani, Ivano Mezzaroma · 2023 · Biomedicines
16. Galectin-9 Is Rapidly Released During Acute HIV-1 Infection and Remains Sustained at High Levels Despite Viral Suppression Even in Elite Controllers
    Ravi Tandon, Glen M. Chew, Mary Margaret Byron, Persephone Borrow, Toshiro Niki, Mitsuomi Hirashima, Jason D. Barbour, Philip J. Norris, Marion C. Lanteri, Jeffrey N. Martin et al. · 2014 · AIDS Research and Human Retroviruses
17. PTSD co-morbid with HIV: Separate but equal, or two parts of a whole?
    Gretchen N. Neigh, Siara T. Rhodes, Arielle N. Valdez‐Sinon, Tanja Jovanović · 2015 · Neurobiology of Disease
18. Inside Out: HIV, the Gut Microbiome, and the Mucosal Immune System
    Jay Liu, Brett Williams, Daniel N. Frank, Stephanie M. Dillon, Cara C. Wilson, ALAN L. LANDAY · 2017 · The Journal of Immunology
19. Progression of Carotid Intima-Media Thickness in a Contemporary Human Immunodeficiency Virus Cohort
    Jeffrey V. Baker, W. Keith Henry, P. Patel, Timothy J. Bush, Lois J. Conley, Wendy Jean Mack, Edgar Turner Overton, Matthew Jay Budoff, John Hammer, Charles C. J. Carpenter et al. · 2011 · Clinical Infectious Diseases
20. Cardiovascular implications from untreated human immunodeficiency virus infection
    Jeffrey V. Baker, Jens Dilling Lundgren · 2011 · European Heart Journal
21. Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals
    Yirui Xie, Jia Sun, Li Wei, Hai‐yin Jiang, Caiqin Hu, Jiezuan Yang, Ying Huang, Bing Ruan, Biao Zhu · 2021 · BMC Microbiology
22. Serious Non-AIDS events: Immunopathogenesis and interventional strategies
    Denise C. Hsu, Irini Sereti, Jintanat Ananworanich · 2013 · AIDS Research and Therapy
23. Lipid Abnormalities in Persons Living With HIV Infection
    David D. Waters, Priscilla Y. Hsue · 2018 · Canadian Journal of Cardiology
24. Plasma Metabolic Signature and Abnormalities in HIV-Infected Individuals on Long-Term Successful Antiretroviral Therapy
    Hemalatha Babu, Maike Sperk, Anoop T. Ambikan, Gladys Rachel, Vinod Kumar Viswanathan, Srikanth Prasad Tripathy, Piotr Nowak, Luke Elizabeth Hanna, Ujjwal Neogi · 2019 · Metabolites
25. Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy
    Cynthia L. Gay, Oliver Dibben, Jeffrey A. Anderson, Andrea Stacey, Ashley Mayo, Philip J. Norris, JoAnn D. Kuruc, Jesus F. Salazar-Gonzalez, Hui Li, Brandon F. Keele et al. · 2011 · PLoS ONE
26. Role of immune activation in progression to AIDS
    Netanya Sandler Utay, Peter W. Hunt · 2016 · Current Opinion in HIV and AIDS
27. Inflammation-Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It?
    Brian B. Hart, Anna D. Nordell, Jason F. Okulicz, Adrian Palfreeman, Andrzej Horban, Eynat Kedem, Jacqueline Neuhaus, David R. Jacobs, Daniel A. Duprez, James D. Neaton et al. · 2017 · JAIDS Journal of Acquired Immune Deficiency Syndromes
28. Association of Low Level Viremia with Inflammation and Mortality in HIV-Infected Adults
    Abigail Eastburn, Rebecca Scherzer, Andrew R. Zolopa, Constance Ann Benson, Russell P. Tracy, Tri Do, Peter Bacchetti, Michael G. Shlipak, Carl Grünfeld, Phyllis C. Tien · 2011 · PLoS ONE
29. Contribution of Intestinal Barrier Damage, Microbial Translocation and HIV-1 Infection Status to an Inflammaging Signature
    Amanda K. Steele, Eric J. Lee, Brian E. Vestal, Daniel K. Hecht, Zachary M. Dong, Eric L. Rapaport, John R. Koeppe, Thomas Campbell, Cara C. Wilson · 2014 · PLoS ONE
30. Extracellular vesicles and chronic inflammation during HIV infection
    Paula S. Pérez, Marìa Albertina Romaniuk, Gabriel Duette, Zezhou Zhao, Yiyao Huang, Lorena Martin Jaular, Kenneth Whitaker Witwer, Clotilde Théry, Matías Ostrowski · 2019 · Journal of Extracellular Vesicles
31. Biomarkers and HIV-associated cardiovascular disease
    Jason V. Baker, Daniel A. Duprez · 2010 · Current Opinion in HIV and AIDS
32. Neuroinflammation in HIV-associated depression: evidence and future perspectives
    Arish Mudra Rakshasa-Loots, Heather Clare Whalley, Jaime H. Vera, Simon R. Cox · 2022 · Molecular Psychiatry
33. HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation
    Jason V. Baker, Kathleen E. Brummel‐Ziedins, Jacqueline Neuhaus, Daniel A. Duprez, Nathan W. Cummins, David Dalmau, Jack A. DeHovitz, Clara Lehmann, Ann Kathleen Sullivan, Ian John Woolley et al. · 2013 · Journal of the American Heart Association
34. HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative
    David B. Hanna, Mengye Guo, Petra Bůžková, Tracie L. Miller, Wendy S. Post, James H. Stein, Judith S. Currier, Richard A. Kronmal, Matthew S. Freiberg, Siiri Bennett et al. · 2016 · Clinical Infectious Diseases
35. Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment
    Olof Elvstam, Patrik Medstrand, Aylin Yilmaz, Per‐Erik Isberg, Magnus Gisslén, Per Björkman · 2017 · PLoS ONE
36. Reduction of HIV Persistence Following Transplantation in HIV-Infected Kidney Transplant Recipients
    Peter G. Stock, Burc Barin, Hiroyu Hatano, Rodney Rogers, Michelle E. Roland, T.-H. Lee, Michael Paul Busch, Steven G. Deeks · 2014 · American Journal of Transplantation
37. Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV
    Caitlin Wei‐Ming Watson, Emily W. Paolillo, Erin E. Morgan, Anya Umlauf, Erin E. Sundermann, Ronald J. Ellis, Scott Lee Letendre, Thomas D. Marcotte, Robert K. Heaton, Igor Grant · 2019 · JAIDS Journal of Acquired Immune Deficiency Syndromes
38. Managing HIV‐associated inflammation and ageing in the era of modern ART
    Mark Theo Bloch, Mina John, Don E. Smith, Thomas A. Rasmussen, Edwina Wright · 2020 · HIV Medicine
39. Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV ‐infected children
    TL Miller, William Borkowsky, Linda Anne DiMeglio, Laurie B. Dooley, Mitchell E. Geffner, Rohan Hazra, EJ McFarland, Armando J. Mendez, Kunjal Patel, George Kelly Siberry et al. · 2011 · HIV Medicine
40. Risks of cardiovascular or central nervous system adverse events and immune reconstitution inflammatory syndrome, for dolutegravir versus other antiretrovirals
    Andrew Martin Hill, Nikkita Mitchell, Sophie L. Hughes, Anton Pozniak · 2017 · Current Opinion in HIV and AIDS
41. Safety, Efficacy, and Pharmacokinetics of TBR-652, a CCR5/CCR2 Antagonist, in HIV-1–Infected, Treatment-Experienced, CCR5 Antagonist–Naive Subjects
    Jacob Paul Lalezari, Joseph Gathe, Cynthia C Brinson, Melanie Thompson, Calvin J. Cohen, Edwin DeJesus, Jorge Galindez, Jerome A. Ernst, David E. Martin, Sandra M. Palleja · 2011 · JAIDS Journal of Acquired Immune Deficiency Syndromes
42. Associations between immune depression and cardiovascular events in HIV infection
    Caroline Anne Sabin, Lene Ryom, Stéphane De Wit, Amanda Mocroft, Andrew N. Phillips, Signe Westring Worm, Rainer K. Weber, Antonella d’Arminio Monforte, Peter Reiss, David A Kamara et al. · 2013 · AIDS
43. Reduced sTWEAK and Increased sCD163 Levels in HIV-Infected Patients: Modulation by Antiretroviral Treatment, HIV Replication and HCV Co-Infection
    Luis M. Beltrán, Rocío Múñoz‐Hernández, Rebeca S. De Pablo-Bernal, José Salvador García Morillo, Jesús Egido, Leal Noval M, Sara Ferrando‐Martínez, Luis Miguel Blanco‐Colio, Miguel Genebat, Jose Ramon Villar et al. · 2014 · PLoS ONE
44. High Abundance of genus Prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy
    Urvinder Kaur Sardarni, Anita Shet, Niharika Rajnala, Bindu Parachalil Gopalan, Preeti Moar, D Himanshu, Balendra Pratap Singh, Rupesh Chaturvedi, Ravi Tandon · 2018 · Scientific Reports
45. Effect of Statin Therapy in Reducing the Risk of Serious Non-AIDS-Defining Events and Nonaccidental Death
    Edgar Turner Overton, Douglas W. Kitch, Constance Ann Benson, Peter W. Hunt, James H. Stein, Marlene Smurzynski, Heather Jane Ribaudo, Pablo Tebas · 2013 · Clinical Infectious Diseases
46. Interleukin-6, High Sensitivity C-Reactive Protein, and the Development of Type 2 Diabetes Among HIV-Positive Patients Taking Antiretroviral Therapy
    Claude Béténé A Dooko, Stéphane De Wit, Jacqueline Neuhaus, Adrian Palfreeman, Rosalie Pepe, James S. Pankow, James D. Neaton · 2014 · JAIDS Journal of Acquired Immune Deficiency Syndromes
47. Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study
    Suhaib Hattab, Amélie Guihot, Marguerite Guiguet, Slim Fourati, Guislaine Carcelain, Fabienne Caby, Anne‐Geneviève Marcelin, Brigitte Autran, Dominique G. Costagliola, Christine Katlama · 2014 · BMC Infectious Diseases
48. Potential Cardiovascular Disease Risk Markers Among HIV-Infected Women Initiating Antiretroviral Treatment
    Robert C. Kaplan, ALAN L. LANDAY, Howard Neil Hodis, Stephen J. Gange, Philip J. Norris, Mary Young, Kathryn Anastos, Phyllis C. Tien, Xiaonan Xue, Jason Lazar et al. · 2012 · JAIDS Journal of Acquired Immune Deficiency Syndromes
49. HIV-Related Metabolic Comorbidities in the Current ART Era
    Amy H. Warriner, Greer Burkholder, Edgar Turner Overton · 2014 · Infectious Disease Clinics of North America
50. Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy
    Duale Ahmed, David Roy, Edana Cassol · 2018 · Mediators of Inflammation
51. Chronic Inflammation and the Role for Cofactors (Hepatitis C, Drug Abuse, Antiretroviral Drug Toxicity, Aging) in HAND Persistence
    Alexander J. Gill, Dennis L. Kolson · 2014 · Current HIV/AIDS Reports
52. Morbidity in older HIV-infected patients: impact of long-term antiretroviral use.
    Giovanni Guaraldi, Manyu Prakash, Christiane Moecklinghoff, Hans‐Jürgen Stellbrink · 2014 · PubMed
53. D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events
    Matthew S. Freiberg, Ionut Bebu, Russell P. Tracy, Kaku So‐Armah, Jason F. Okulicz, Anuradha Ganesan, Adam W. Armstrong, Thomas A. O’Bryan, David Rimland, Amy C. Justice et al. · 2016 · PLoS ONE
54. Inflammation and Metabolic Complications in HIV
    Kassem Bourgi, Celestine N. Wanjalla, John Robert Koethe · 2018 · Current HIV/AIDS Reports
55. Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314
    Priscilla Y. Hsue, Heather Jane Ribaudo, Steven G. Deeks, Tanvir K. Bell, Paul M. Ridker, Carl J. Fichtenbaum, Eric S. Daar, Diane V. Havlir, Eunice Yeh, Ahmed A Tawakol et al. · 2018 · Clinical Infectious Diseases
56. Differences between HIV ‐infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case–control studies
    M Calvo‐Sánchez, Rafel Perelló, Ignacio Pérez, M. Gracia Mateo, Mireia Junyent, Montserrat Laguno, JL Blanco, Maria Martínez‐Rebollar, M Sánchez, Josep Mallolas et al. · 2012 · HIV Medicine
57. Safety, Tolerability, and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV-Infected Patients Receiving Combination Antiretroviral Therapy
    Benigno A. Rodriguez, David M. Asmuth, Roy M. Matining, John Spritzler, Jeffrey M. Jacobson, Robbie B. Mailliard, Xiao-Dong Li, Ana I. Martínez, Allan R. Tenorio, Franco Lori et al. · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
58. Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients
    Fowzia Ibrahim, Lisa Hamzah, Rachael Jones, Dorothea Nitsch, Caroline Anne Sabin, Frank A. Post · 2012 · American Journal of Kidney Diseases
59. Achieving a cure for HIV infection: do we have reasons to be optimistic?
    Valentin Le Douce, Andrea Janossy, Houda Hallay, Sultan Ali, Raphaël Riclet, Olivier Rohr, Christian Schwartz · 2012 · Journal of Antimicrobial Chemotherapy
60. The paradox of the immune response in HIV infection: When inflammation becomes harmful
    Hayley Ipp, Annalise E. Zemlin · 2012 · Clinica Chimica Acta
61. HIV stroke risk: evidence and implications
    Elyse J. Singer, Miguel Valdes‐Sueiras, Deborah Commins, William H. Yong, Margrit Carlson · 2013 · Therapeutic Advances in Chronic Disease
62. Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection
    Boghuma Kabisen Titanji, Christina Gavegnano, Priscilla Y. Hsue, Raymond F. Schinazi, Vincent C. Marconi · 2020 · Journal of the American Heart Association
63. Coagulation and morbidity in treated HIV infection
    Nicholas Funderburg, Michael M. Lederman · 2014 · Thrombosis Research
64. Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development
    Sheila Marie Keating, Evan S. Jacobs, Philip J. Norris · 2012 · Cytokine & Growth Factor Reviews
65. Accelerated Aging in HIV Patients
    Keren Meir‐Shafrir, Shimon Pollack · 2012 · Rambam Maimonides Medical Journal
66. Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy
    Josep Maria Llibre, José Ramón Arribas, Peré Domingo, Josep M. Gatell, Fernando Lozano, José Ramón Santos, Antonio Rivero, Santiago Moreno, Bonaventura Clotet · 2011 · AIDS
67. Lipid Metabolism in Treated HIV Infection
    Michael P. Dubé, Joseph J. Cadden · 2011 · Best Practice & Research Clinical Endocrinology & Metabolism
68. Untangling the Gordian knot of HIV, stress, and cognitive impairment
    Arielle N. Valdez‐Sinon, Leah H. Rubin, Gretchen N. Neigh · 2016 · Neurobiology of Stress
69. Kidney transplantation in HIV-positive adults: the UK experience
    Esther Gathogo, Lisa Hamzah, Rachel M. Hilton, Neal Marshall, Caroline Ashley, Mark A Harber, Jeremy B Levy, Rachael Jones, Marta Boffito, Saye Khoo et al. · 2013 · International Journal of STD & AIDS
70. Renal complications in HIV disease: between present and future.
    Paolo Maggi, Dario Bartolozzi, Paolo Bonfanti, Leonardo Calza, Chiara Cherubini, Antonio Di Biagio, Simone Marcotullio, Francesco Montella, Vincenzo Montinaro, Cristina Mussini et al. · 2012 · PubMed
71. A randomized, controlled trial of mindfulness-based stress reduction in HIV infection
    Hecht, Frederick M., Moskowitz, Judith T., Moran, Patricia, Epel, Elissa S., Bacchetti, Peter, Acree, Michael, Kemeny, Margaret E., Mendes, Wendy Berry, Duncan, Larissa G., Weng, Helen et al. · 2018 · Brain Behavior and Immunity
72. Changes in Causes of Death Among Persons with AIDS: San Francisco, California, 1996–2011
    Sandra K. Schwarcz, Annie Vu, Ling Chin Hsu, Nancy A. Hessol · 2014 · AIDS Patient Care and STDs
73. HIV RNA Suppression and Immune Restoration: Can We Do Better?
    Marilia Rita Pinzone, Michelino Di Rosa, Bruno Santi Cacopardo, Giuseppe Nunnari · 2012 · Clinical and Developmental Immunology
74. Chronic HIV disease and activation of the coagulation system
    Jason V. Baker · 2013 · Thrombosis Research
75. Elevated Biomarkers of Inflammation and Coagulation in Patients with HIV Are Associated with Higher Framingham and VACS Risk Index Scores
    Sarah Mooney, Russell P. Tracy, Turner M. Osler, Christopher J. Grace · 2015 · PLoS ONE
76. The chemistry of gut microbiome in health and diseases
    Agnes Lau, Loh Teng‐Hern Tan, Nurul‐Syakima Ab Mutalib, Sunny Hei Wong, Vengadesh Letchumanan, Learn−Han Lee · 2021 · Progress In Microbes & Molecular Biology
77. Correlates of Elevated Interleukin-6 and C-Reactive Protein in Persons With or at High Risk for HCV and HIV Infections
    Megan L. Salter, Bryan M. Lau, Shruti H. Mehta, Vivian Fei-ling Go, Sean Xiao Leng, Gregory Dale Kirk · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
78. Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus
    Juan Antonio Moreno, Luis M. Beltrán, Alfonso Rubio‐Navarro, Juan García Puig, Juan Manuel Amaro-Villalobos, Jesús Egido · 2015 · Vascular Health and Risk Management
79. Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy
    Lois J. Conley, Timothy J. Bush, Adam W. Rupert, Irini Sereti, Pragna Patel, John T. Brooks, Jason V. Baker · 2015 · AIDS
80. Tobacco Use and Cessation in HIV-Infected Individuals
    Kristine K. Browning, Mary Ellen Wewers, Amy K. Ferketich, Philip Diaz · 2013 · Clinics in Chest Medicine
81. Association of Biomarker Clusters With Cardiac Phenotypes and Mortality in Patients With HIV Infection
    Rebecca Scherzer, Sanjiv Jayendra Shah, Eric Alexander Secemsky, Javed Butler, Carl Grünfeld, Michael G. Shlipak, Priscilla Y. Hsue · 2018 · Circulation Heart Failure
82. Prevalence, Risk Factors, and Pathophysiology of Dysglycemia among People Living with HIV in Sub-Saharan Africa
    Benson Njuguna, Jepchirchir Kiplagat, Gerald S. Bloomfield, Sonak Dinesh Pastakia, Rajesh Vedanthan, John Robert Koethe · 2018 · Journal of Diabetes Research
83. Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV
    Caitlin Wei‐Ming Watson, Laura M. Campbell, Ni Sun-Suslow, Suzi Hong, Anya Umlauf, Ronald J. Ellis, Jennifer E. Iudicello, Scott Lee Letendre, Thomas D. Marcotte, Robert K. Heaton et al. · 2021 · Journal of the International Neuropsychological Society
84. Non‐linear resistance training reduces inflammatory biomarkers in persons living with HIV: A randomized controlled trial
    Hugo Ribeiro Zanetti, Lucas Gonçalves da Cruz, Camilo Luís Monteiro Lourenço, Fernando de Freitas Neves, Mário León Silva-Vergara, Edmar Lacerda Mendes · 2016 · European Journal of Sport Science
85. Increased risk of dysglycaemia in South Africans with HIV; especially those on protease inhibitors
    Naomi Sharlene Levitt, Nasheeta Peer, Krisela Steyn, Carl J. Lombard, Gary Maartens, Estelle Victoria Lambert, Joel Alex Dave · 2016 · Diabetes Research and Clinical Practice
86. Assessing inflammation and its role in comorbidities among persons living with HIV
    Tess E. Peterson, Jason V. Baker · 2018 · Current Opinion in Infectious Diseases
87. Systemic Inflammation Associated with Immune Reconstitution Inflammatory Syndrome in Persons Living with HIV
    Caian L. Vinhaes, Mariana Araújo‐Pereira, Rafael Tibúrcio, Juan Manuel Cubillos-Angulo, Fernanda O. Demitto, Kevan Akrami, Bruno B. Andrade · 2021 · Life
88. Lessons learned from the first wave of aging with HIV
    Amy C. Justice, Ronald Scott Braithwaite · 2012 · AIDS
89. Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns
    Francesca Falasca, Daniele Di Carlo, Corrado De Vito, Isabella Bon, Gabriella d’Ettorre, Alessandra Fantauzzi, Ivano Mezzaroma, Caterina Fimiani, Maria Carla Re, Vincenzo Vullo et al. · 2017 · BMC Infectious Diseases
90. Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity
    Jean‐Philippe Bastard, Soraya Fellahi, Camille Couffignal, François Raffi, Guillaume Gras, Lucile Hardel, Alain T. Sobel, Catherine Leport, Laurence Fardet, Jacqueline Capeau et al. · 2015 · Journal of Antimicrobial Chemotherapy
91. Eliminating the latent HIV reservoir by reactivation strategies: Advancing to clinical trials
    Thomas A. Rasmussen, Martin Tolstrup, Anni Assing Winckelmann, Lars Jørgen Østergaard, Ole Schmeltz Søgaard · 2013 · Human Vaccines & Immunotherapeutics
92. Dyslipidemia, chronic inflammation, and subclinical atherosclerosis in children and adolescents infected with HIV: The PositHIVe Health Study
    Luiz Rodrigo Augustemak de Lima, Edio Luiz Petróski, Yara María Franco Moreno, Diego Augusto Santos Silva, Erasmo Benício Santos de Moraes Trindade, Aroldo Prohmann de Carvalho, Isabela de Carlos Back · 2018 · PLoS ONE
93. Cardiovascular disease and risk assessment in people living with HIV: Current practices and novel perspectives
    Paraskevi C. Fragkou, Charalampos D. Moschopoulos, Dimitra Dimopoulou, Helen Triantafyllidi, Dionysia Birmpa, Dimitrios Benas, Sotirios Tsiodras, Dimitra Kavatha, Anastasia Antoniadou, Antonios Papadopoulos · 2023 · Hellenic Journal of Cardiology
94. Dyslipidemia in Human Immunodeficiency Virus Disease
    Dinesh Kumar Kalra, Mounica Vorla, Erin D. Michos, Anandita Agarwala, Salim S. Virani, Paul Barton Duell, Frederick Johan Raal · 2023 · Journal of the American College of Cardiology
95. The Effect of HIV and HPV Coinfection on Cervical COX-2 Expression and Systemic Prostaglandin E2 Levels
    Daniel W. Fitzgerald, Karl B. Bezak, Oksana Ocheretina, Cynthia Riviere, Thomas C. Wright, Ginger L. Milne, Xi Kathy Zhou, Baoheng Du, Kotha Subbaramaiah, Erin Byrt et al. · 2011 · Cancer Prevention Research
96. Bronchiectasis and other chronic lung diseases in adolescents living with HIV
    Engi Farouk Attia, Robert F. Miller, Rashida A. Ferrand · 2016 · Current Opinion in Infectious Diseases
97. Human immunodeficiency virus and mortality from coronavirus disease 2019: A systematic review and meta-analysis
    Timotius Ivan Hariyanto, Jane Rosalind, Kevin Christian, Andree Kurniawan · 2021 · Southern African Journal of HIV Medicine
98. Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population
    Lisa Kakinami, Robert Block, M. Jacob Adams, Susan E. Cohn, Benedict J. Maliakkal, Susan Gross Fisher · 2012 · International Journal of Clinical Practice
99. Persisting Inflammation and Chronic Immune Activation but Intact Cognitive Function in HIV-Infected Patients After Long-Term Treatment With Combination Antiretroviral Therapy
    Karin Kaereby Pedersen, Maria Pedersen, Julie Christine Gaardbo, Andreas Ronit, Hans Jakob Hartling, Helle Brüünsgaard, Jan Gerstoft, Henrik Ullum, Susanne Dam Nielsen · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
100. HIV and aging
     Peter W. Hunt · 2014 · Current Opinion in HIV and AIDS